1. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.
- Author
-
Agarwal A, Ghose N, Rathi V, Khanna R, and Kaliki S
- Subjects
- Humans, Male, Middle Aged, Female, Retrospective Studies, Adult, India epidemiology, Aged, Adolescent, Young Adult, Eye Neoplasms drug therapy, Eye Neoplasms epidemiology, Eye Neoplasms diagnosis, Eye Neoplasms therapy, Antimetabolites, Antineoplastic therapeutic use, Rural Population, Ophthalmic Solutions, Conjunctival Neoplasms drug therapy, Conjunctival Neoplasms therapy, Conjunctival Neoplasms pathology, Conjunctival Neoplasms epidemiology, Follow-Up Studies, Fluorouracil therapeutic use, Fluorouracil administration & dosage, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Corneal Diseases diagnosis, Corneal Diseases drug therapy, Corneal Diseases epidemiology
- Abstract
Purpose: To report the demographic profile, clinical presentation, and management outcomes of ocular surface squamous neoplasia (OSSN) treated with primary topical chemotherapy in a limited resource secondary eye care facility in rural parts of South India., Methods: Retrospective interventional study of 38 eyes of 37 patients with OSSN treated with topical 1% 5-Fluorouracil (5FU), over a period of two years., Results: The median age at presentation with OSSN was 44 years (mean, 46 years; range 13 to 74 years). Majority (76%) were males. The most common morphological variant was placoid OSSN (18, 47%). Limbus was the most common epicenter (31, 82%). Corneal OSSN was the most initially misdiagnosed variant (n = 3). Of the 38 eyes receiving one week on and 3-weeks off cycles of 5FU regimen, complete tumor resolution was achieved in 36 (95%) eyes. The median number of topical 5FU cycles for tumor resolution was 2 (mean, 2; range, 1 to 4). Over a median follow-up period of 5 months (mean, 6 months; range, 1 to 27 months), tumor recurrence was noted in 3 eyes (8%), of which one case had xeroderma pigmentosum with bilateral multifocal recurrence. Complication rate was 5% (n = 2), which included transient conjunctival hyperemia (n = 1), and bacterial keratitis (n = 1) which resolved with fortified antibiotics., Conclusion: Primary chemotherapy with topical 1% 5FU is a safe and effective management modality for OSSN at limited resource settings in rural India., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF